Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122968522 | 12296852 | 2 | F | 20160321 | 20160422 | 20160819 | PER | US-TAKEDA-2016MPI003126 | TAKEDA | 0.00 | M | Y | 98.00000 | KG | 20160819 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122968522 | 12296852 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | UNK, 2/WEEK | Y | UNKNOWN | 21602 | INJECTION | BIW | ||||||
| 122968522 | 12296852 | 2 | SS | PANOBINOSTAT | PANOBINOSTAT | 1 | Oral | UNK, 3/WEEK | U | 0 | TIW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122968522 | 12296852 | 1 | Plasma cell myeloma |
| 122968522 | 12296852 | 2 | Plasma cell myeloma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122968522 | 12296852 | Drug effect decreased | |
| 122968522 | 12296852 | Fatigue | |
| 122968522 | 12296852 | Insomnia | |
| 122968522 | 12296852 | Neuropathy peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122968522 | 12296852 | 1 | 2015 | 0 | ||
| 122968522 | 12296852 | 2 | 2015 | 0 |